Immediate withdrawal from chronic "binge" cocaine administration increases μ-opioid receptor mRNA levels in rat frontal cortex

Molecular Brain Research

Volumn 137, Issue 1-2, 2005, Pages 258-262

  Bailey, Alexis ^a   Yuferov, Vadim ^a   Bendor, Jacob ^a   Schlussman, Stefan D ^a   Zhou, Yan ^a   Ho, Ann ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

"Binge" cocaine administration; Opioid receptor; Frontal cortex; Naloxone; Withdrawal

Indexed keywords

COCAINE; MESSENGER RNA; MU OPIATE RECEPTOR; NALOXONE; PREPRODYNORPHIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG WITHDRAWAL; FRONTAL CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT;

ANIMALS; BRAIN CHEMISTRY; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; ENKEPHALINS; FRONTAL LOBE; MALE; NARCOTIC ANTAGONISTS; PROTEIN PRECURSORS; RATS; RATS, INBRED F344; RECEPTORS, OPIOID, MU; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 20444384773     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2005.02.017     Document Type: Article

References (47)

1. A.V. Azaryan, B.J. Clock, and B.M. Cox μ Opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation Neurochem. Res. 21 1996 1411 1415
2. A.V. Azaryan, B.J. Clock, J.G. Rosenberger, and B.M. Cox Transient upregulation of μ opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration Can. J. Physiol. Pharmacol. 76 1998 278 283
3. A.D. Branch, E.M. Unterwald, S.E. Lee, and M.J. Kreek Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay Mol. Brain Res. 14 1992 231 238
4. 2a-adrenoceptor mRNA in brain Mol. Brain Res. 45 1997 154 158
5. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
6. J.B. Daunais, and J.F. McGinty Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs Synapse 18 1994 35 45
7. J.B. Daunais, and J.F. McGinty Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs Mol. Brain Res. 29 1995 201 210
8. J.B. Daunais, D.C. Roberts, and J.F. McGinty Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum NeuroReport 4 1993 543 546
9. X.L. Fan, J.S. Zhang, X.Q. Zhang, W. Yue, and L. Ma Differential regulation of [beta]-arrestin 1 and [beta]-arrestin 2 gene expression in rat brain by morphine Neuroscience 117 2003 383 389
10. F. Gawin Cocaine addiction: psychology and neurophysiology Science 251 1991 1580 1586
11. M.A. Gerrits, N. Patkina, E.E. Zvartau, and J.M. van-Ree Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats Psychopharmacology 119 1995 92 98
12. A.A. Houdi, M.T. Bardo, and G.R. Van-Loon Opioid mediation of cocaine-induced hyperactivity and reinforcement Brain Res. 497 1989 195 198
13. Y.L. Hurd, E.E. Brown, J.M. Finlay, H.C. Fibiger, and C.R. Gerfen Cocaine self-administration differentially alters mRNA expression of striatal peptides Mol. Brain Res. 13 1992 165 170
14. E.A. Kiyatkin, and P.L. Brown Naloxone depresses cocaine self-administration and delays its initiation on the following day NeuroReport 14 2003 251 255
15. M.J. Kreek Cocaine, dopamine and the endogenous opioid system J. Addict. Dis. 15 1996 73 96
16. M.J. Kreek Opiates, opioids and addiction Mol. Psychiatry 1 1996 232 254
17. M.J. Kreek, K.S. LaForge, and E. Butelman Pharmacotherapy of addictions Nat. Rev. 1 2002 710 726
18. A.V. Kuzmin, M.A. Gerrits, J.M. van-Ree, and E.E. Zvartau Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice Life Sci. 60 1997 257 264
19. Y. Li, X.T. Hu, T.G. Berney, A.J. Vartanian, C.D. Stine, M.E. Wolf, and F.J. White Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations Synapse 34 1999 169 180
20. I.M. Maisonneuve, A. Ho, and M.J. Kreek Chronic administration of a cocaine "binge" alters basal extracellular levels in male rats: an in vivo microdialysis study J. Pharmacol. Exp Ther. 272 1995 652 657
21. A.M. Mathieu-Kia, and M.J. Besson Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat Mol. Brain Res. 54 1998 141 151
22. J. Neisewander, I. Lucki, and P. McGonigle Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats Synapse 16 1994 1 10
23. R.C. Pierce, D.C. Reeder, J. Hicks, Z.R. Morgan, and P.W. Kalivas Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine Neuroscience 82 1998 1103 1114
24. B. Przewlocka, and W. Lason Adaptive changes in the proenkephalin and D2 dopamine receptor mRNA expression after chronic cocaine in the nucleus accumbens and striatum of the rat Eur. Neuropsychopharmacol. 5 1995 465 469
25. R. Spanagel, A. Herz, and T.S. Shippenberg The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study J. Neurochem. 55 1990 1734 1740
26. R. Spanagel, A. Herz, and T.S. Shippenberg Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway Proc. Natl. Acad. Sci. U. S. A. 89 1992 2046 2050
27. R. Spangler, E.M. Unterwald, and M.J. Kreek "Binge" cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen Mol. Brain Res. 19 1993 323 327
28. R. Spangler, A. Ho, Y. Zhou, C.E. Maggos, V. Yuferov, and M.J. Kreek Regulation of κ opioid receptor mRNA in the rat brain by "binge" pattern cocaine administration and correlation with preprodynorphin mRNA Brain Res. Mol. Brain Res. 38 1996 71 76
29. R. Spangler, Y. Zhou, C.E. Maggos, A. Zlobin, A. Ho, and M.J. Kreek Dopamine antagonist and "binge" cocaine effects on rat opioid and dopamine transporter mRNAs NeuroReport 7 1996 2196 2200
30. R. Spangler, Y. Zhou, C.E. Maggos, S.D. Schlussman, A. Ho, and M.J. Kreek Prodynorphin, proenkephalin and κ opioid receptor mRNA responses to acute "binge" cocaine Mol. Brain Res. 44 1997 139 142
31. H. Steiner, and C.R. Gerfen Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum J. Neurosci. 13 1993 5066 5081
32. 1 dopamine receptor messenger RNAs during cocaine abstinence Mol. Brain Res. 56 1998 162 168
33. J. Turchan, B. Przewlocka, W. Lason, and R. Przewlocki Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain Neuroscience 85 1998 1051 1059
34. T.M. Tzschentke, and W.J. Schmidt The development of cocaine-induced behavioral sensitization is affected by discrete quinolinic acid lesions of the prelimbic medial prefrontal cortex Brain Res. 795 1998 71 76
35. T.M. Tzschentke, and W.J. Schmidt Discrete quinolinic acid lesions of the rat prelimbic medial prefrontal cortex affect cocaine- and MK-801-, but not morphine- and amphetamine-induced reward and psychomotor activation as measured with the place preference conditioning paradigm Behav. Brain Res. 97 1998 115 127
36. T.M. Tzschentke, and W.J. Schmidt Functional heterogeneity of the rat medial prefrontal cortex: effects of discrete subarea-specific lesions on drug-induced conditioned place preference and behavioural sensitization Eur. J. Neurosci. 11 1999 4099 4109
37. T.M. Tzschentke, and W.J. Schmidt Differential effects of discrete subarea-specific lesions of the rat medial prefrontal cortex on amphetamine- and cocaine-induced behavioural sensitization Cereb. Cortex 10 2000 488 498
38. E.M. Unterwald Regulation of opioid receptors by cocaine Ann. N. Y. Acad. Sci. 937 2001 74 92
39. E.M. Unterwald, J. Horne-King, and M.J. Kreek Chronic cocaine alters brain μ opioid receptors Brain Res. 584 1992 314 318
40. E.M. Unterwald, J.M. Rubenfeld, and M.J. Kreek Repeated cocaine administration upregulates κ and μ, but not δ, opioid receptors NeuroReport 5 1994 1613 1616
41. E.M. Unterwald, J.M. Rubenfeld, Y. Imai, J.B. Wang, G.R. Uhl, and M.J. Kreek Chronic opioid antagonist administration upregulates μ opioid receptor binding without altering μ opioid receptor mRNA levels Brain Res. Mol. Brain Res. 33 1995 351 355
42. M. Waldhoer, S.E. Bartlett, and J.L. Whistler Opioid receptors Annu. Rev. Biochem. 73 2004 953 990
43. M. Werme, P. Thoren, L. Olson, and S. Brene Running and cocaine both upregulate dynorphin mRNA in medial caudate putamen Eur. J. Neurosci. 12 2000 2967 2974
44. P.L. Wood, M. Stotland, J.W. Richard, and A. Rackham Actions of μ, κ, σ, δ and agonist/antagonist opiates on striatal dopaminergic function J. Pharmacol. Exp. Ther. 215 1980 697 703
45. V. Yuferov, Y. Zhou, R. Spangler, C.E. Maggos, A. Ho, and M.J. Kreek Acute "binge" cocaine increases μ opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system Brain Res. Bull. 48 1999 109 112
46. V. Zachariou, J. Thome, K. Parikh, and M.R. Picciotto Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal Neuropsychopharmacology 23 2000 127 137
47. Y. Zhang, E. Butelman, S.D. Schlussman, A. Ho, and M.J. Kreek Effect of the endogenous κ opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced preference in C57BL/6J mice Psychopharmacology 172 2004 422 429